AGP Executive Report
Last update: 7 hours agoMedicare Access: CMS’s Medicare GLP-1 Bridge Program (launched July 1) is pushing Wegovy, Zepbound and “Foundayo” toward a flat $50 monthly co-pay for eligible beneficiaries, with Amazon Pharmacy handling eligibility, prior authorization and billing. Policy & Oversight: India’s health ministry tightened drug approval rules, adding debarment for applicants submitting fake data, with show-cause and appeal steps. Device Regulation: Public Citizen urged FDA to strengthen Medical Device User Fee Amendments language by boosting consumer input and adding clearer performance measures tied to health outcomes. Workplace Women’s Health: A global survey found 70% of women lose 1–5 workdays monthly due to women’s health issues, but only 10% feel supported—pushing women’s health as a business resilience priority. Heat & Care Delivery: UK reporting highlights rising heatwave harm, with NHS and public health warnings that vulnerable groups and common meds can raise risk. Tech in Care: Vexev is raising $6M for an autonomous, robot- and AI-based vascular imaging platform starting with dialysis patients. Clinical/Company Moves: Omada Health posted strong Q2 growth and leadership transition plans; Health Catalyst reported results after closing a divestiture and repaying debt.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
